What can multiple myeloma patients try if they relapse current medications or treatments early? Or if the relapses continue and they become refractory to treatment? With newer drugs now available in the clinic, picking the right combinations at the right time is key for patients. Learn how to educate yourself about the current options and how to position yourself for your best care.

Dr. Andrzej Jakubowiak, MD, PhD of the University of Chicago is a myeloma expert who is deeply involved in the creation of clinical trials testing these newer combinations. He shares his expertise on the timing, staging and combinations that are being tested in clinical trials and what he is learning from these studies.

Thanks to our episode sponsor, Takeda Oncology

Myeloma Crowd Radio: Dr. Andrzej Jakubowiak, MD, PhD, University of Chicago

Share

Embed